Difference between revisions of "Amir Attaran"
Jump to navigation
Jump to search
Bob Burton (talk | contribs) (add links, cut fluff and relocate some to talk page pending refs) |
|||
| Line 1: | Line 1: | ||
Dr. '''Amir Attaran''' is a lawyer (LL.B., Vancouver) and immunologist (DPhil, Oxford) who writes on public health and global development issues. He has been published in journals such as Nature, the Lancet, the Journal of the American Medicial Association, the Yale International Law Journal, and also in the New York Times, the Globe and Mail, and other publications. His coauthors include development economist Jeffrey Sachs, and Nobel peace prize laureate Shirin Ebadi. | Dr. '''Amir Attaran''' is a lawyer (LL.B., Vancouver) and immunologist (DPhil, Oxford) who writes on public health and global development issues. He has been published in journals such as Nature, the Lancet, the Journal of the American Medicial Association, the Yale International Law Journal, and also in the New York Times, the Globe and Mail, and other publications. His coauthors include development economist Jeffrey Sachs, and Nobel peace prize laureate Shirin Ebadi. | ||
| − | Dr. Attaran has been a paid consultant to NGOs (e.g. Doctors Without Borders), the United Nations (e.g. the UNDP), the pharmaceutical industry (e.g. Novartis), and an unpaid consultant when requested by various developing country governments (e.g. Brazil, Malawi). All his sources of research financing are fully disclosed in his peer-reviewed publications. | + | Dr. Attaran has been a paid consultant to NGOs (e.g. Doctors Without Borders), the United Nations (e.g. the UNDP), the pharmaceutical industry (e.g. [[Novartis]]), and an unpaid consultant when requested by various developing country governments (e.g. Brazil, Malawi). All his sources of research financing are fully disclosed in his peer-reviewed publications. |
| − | He is currently Associate Professor of Law and Population Health, and the holder of | + | He is currently Associate Professor of Law and Population Health, and the holder of the Canada Research Chair at the University of Ottawa, Canada. Previously he was an adjunct lecturer in Public Policy at Harvard University, publishing research as part of the Center for International Development and the Carr Center for Human Rights Policy at the John F. Kennedy School of Government. |
| − | He is a board member of [[Africa Fighting Malaria]], a private organization funded in part by the American Enterprise Institute. He has been a vocal critic against the humanitarian organization Doctors Without Borders | + | He is a board member of [[Africa Fighting Malaria]], a private organization funded in part by the [[American Enterprise Institute]]. He has been a vocal critic against the humanitarian organization Doctors Without Borders in its campaign information on drug patents and medicine access. |
==References== | ==References== | ||
| + | *Royal Institute of International Affairs, [http://www.riia.org/index.php?id=20&eid=114 Dr Amir Attaran], biography, accessed February 2004. | ||
| + | *[http://www.thebody.com/tag/nov01/patent_politics.html Patent Politics], ''TAGline'', Volume 8, Issue 9, November 2001. | ||
| + | *[http://www.accessmed-msf.org/prod/publications.asp?scntid=2812003950572&contenttype=PARA& AIDS Activists Laud Pharmacia Plan for Generic Manufacturing]", Dow Jones International: January 24, 2003. | ||
*[[Consumer Project on Technology]], [http://www.cptech.org/ip/health/pharmadefenders.html Big Pharma's favorite academics and opinion makers], accessed February 2004. | *[[Consumer Project on Technology]], [http://www.cptech.org/ip/health/pharmadefenders.html Big Pharma's favorite academics and opinion makers], accessed February 2004. | ||
*A Critique of Amir Attaran's claims about patents and medicine access, [http://www.accessmed-msf.org/prod/publications.asp?scntid=171020011428553&contenttype=PARA&], [http://content.healthaffairs.org/cgi/eletters/23/3/155], [http://www.cptech.org/ip/health/africa/dopatentsmatterinafrica.html]. | *A Critique of Amir Attaran's claims about patents and medicine access, [http://www.accessmed-msf.org/prod/publications.asp?scntid=171020011428553&contenttype=PARA&], [http://content.healthaffairs.org/cgi/eletters/23/3/155], [http://www.cptech.org/ip/health/africa/dopatentsmatterinafrica.html]. | ||
| − | |||
| − | |||
| − | |||
Revision as of 22:43, 4 September 2005
Dr. Amir Attaran is a lawyer (LL.B., Vancouver) and immunologist (DPhil, Oxford) who writes on public health and global development issues. He has been published in journals such as Nature, the Lancet, the Journal of the American Medicial Association, the Yale International Law Journal, and also in the New York Times, the Globe and Mail, and other publications. His coauthors include development economist Jeffrey Sachs, and Nobel peace prize laureate Shirin Ebadi.
Dr. Attaran has been a paid consultant to NGOs (e.g. Doctors Without Borders), the United Nations (e.g. the UNDP), the pharmaceutical industry (e.g. Novartis), and an unpaid consultant when requested by various developing country governments (e.g. Brazil, Malawi). All his sources of research financing are fully disclosed in his peer-reviewed publications.
He is currently Associate Professor of Law and Population Health, and the holder of the Canada Research Chair at the University of Ottawa, Canada. Previously he was an adjunct lecturer in Public Policy at Harvard University, publishing research as part of the Center for International Development and the Carr Center for Human Rights Policy at the John F. Kennedy School of Government.
He is a board member of Africa Fighting Malaria, a private organization funded in part by the American Enterprise Institute. He has been a vocal critic against the humanitarian organization Doctors Without Borders in its campaign information on drug patents and medicine access.
References
- Royal Institute of International Affairs, Dr Amir Attaran, biography, accessed February 2004.
- Patent Politics, TAGline, Volume 8, Issue 9, November 2001.
- AIDS Activists Laud Pharmacia Plan for Generic Manufacturing", Dow Jones International: January 24, 2003.
- Consumer Project on Technology, Big Pharma's favorite academics and opinion makers, accessed February 2004.
- A Critique of Amir Attaran's claims about patents and medicine access, [1], [2], [3].
